CAS No. |
22318-10-1 |
中文名称 |
(4aS,8aR,8bR,9aS,12S,12aS,14aR,14bR)-12-(3-呋喃基)-7-羟基-6,6,8a,12a-四甲基-4,4a,8a,12,12a,13,14,14a-八氢-1H,3H-环氧[2,3-d]吡喃并[4',3':3,3a]异苯并呋喃并[5,4-f]异色烯-3,8,10(6H,9aH)-三酮 |
英文名称 |
(4aS,8aR,8bR,9aS,12S,12aS,14aR,14bR)-12-(furan-3-yl)-7-hydroxy-6,6,8a,12a-tetramethyl-4,4a,8a,12,12a,13,14,14a-octahydro-1H,3H-oxireno[2,3-d]pyrano[4',3':3,3a]isobenzofuro[5,4-f]isochromene-3,8,10(6H,9aH)-trione |
别名 |
Evodol;(4bR,10bR)-2,4,4a,5aβ,6,8,8a,9,10,10aβ,14,14aβ-Dodecahydro-2,2,4aα,8aβ-tetramethyl-8β-(3-furanyl)-3-hydroxy-13H-oxireno[d]pyrano[4',3':3,3a]isobenzofuro[5,4-f][2]benzopyran-4,6,13-trione;Limonin diosphenol;Glaucin C;11H,13H-Oxireno[d]pyrano[4',3':3,3a]isobenzofuro[5,4-f][2]benzopyran-4,6,13(2H,5aH)-trione,8-(3-furanyl)-4a,8,8a,9,10,10a,14,14a-octahydro-3-hydroxy-2,2,4a,8a-tetraMethyl-,(4aR,4bR,5aS,8S,8aS,10aR,10bR,14aS)-;Evodol >=95% (LC/MS-ELSD);(3S,8S,9S,10R,13S,14S,16R,17R)-17-acetyl-16-(aziridin-1-yl)-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]acetate |
标准英文名 |
(4aS,8aR,8bR,9aS,12S,12aS,14aR,14bR)-12-(furan-3-yl)-7-hydroxy-6,6,8a,12a-tetramethyl-4,4a,8a,12,12a,13,14,14a-octahydro-1H,3H-oxireno[2,3-d]pyrano[4',3':3,3a]isobenzofuro[5,4-f]isochromene-3,8,10(6H,9aH)-trione |
MDL No. |
MFCD20260547 |
分子式 |
C26H28O9 |
分子量 |
484.50
|
精确分子量 |
484.17
|
SMILES |
CC1(C)O[C@H]2CC(=O)OC[C@@]23C1=C(O)C(=O)[C@]1(C)[C@@H]3CC[C@@]2(C)[C@H](C3=COC=C3)OC(=O)[C@H]3O[C@]321 |
标准SMILES |
CC1(C)O[C@H]2CC(=O)OC[C@@]32[C@H]2CC[C@@]4(C)[C@@H](OC(=O)[C@H]5O[C@@]45[C@]2(C)C(=O)C(O)=C13)C1=COC=C1 |
用途 |
Evodol can be used in the preparation of anti-tumor pharmaceuticals, foods, or health supplements; it exhibits anti-tumor activity by inhibiting histone deacetylase; it inhibits nitric oxide (NO) production; it shows larvicidal activity against Aedes albopictus with an LC50 value of 32.43 μg/mL. |
InChIKey |
SNGHLUWTFLYPMT-JPRNBFAHSA-N |